Skip to main content
AgilentLaunch

Agilent Technologies stock gains on digital pathology launch and strong Q3 figures

What happened

Agilent Technologies launched its Agilent S540MD Slide Scanner System in the U.S. after receiving FDA clearance.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Agilent Technologies Inc (ISIN US00846U1016) stock is quoted at 149.98 USD as of September 4, 2026, only 1.1% above an intrinsic value estimate of 148.35 USD, according to data compiled by GuruFocus. On the same day, Agilent announced the U.S. launch of its Agilent S540MD Slide Scanner System following FDA approval, adding a new digital pathology solution to its diagnostics portfolio as highlighted in the news feed at StockTitan. For investors, the combination of a nearly fair valuation and fresh product momentum sets the tone for Agilent Technologies stock today. On September 4, 2026, Agilent Technologies expanded its digital pathology offering in the U.S. with the launch of the Agilent S540MD Slide Scanner System after receiving FDA clearance, according to the company press summary carried in the StockTitan news stream. The scanner is designed for high volume pathology laboratories and can process up to 540 slides, with continuous loading and compatibility with standard racks as described by GuruFocus. That capacity matters because large hospital and reference labs increasingly seek automated workflows that digitize glass slides and integrate into clinical information systems. The S540MD platform uses automated scanning and advanced tissue detection technologies to accelerate slide digitization and support comprehensive digital pathology workflows, again per the...

Keep reading with a free account

The rest of this article, and every signal for Agilent, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Launch

What this signalsA launch often needs new go-to-market and support spend.

Product
Agilent S540MD Slide Scanner System
Takes effect
Sep 4, 2026
Location
United States

The full record

From the Signal API record

Details

Release type
System

Topics and mentions

Product tags

  • medical
  • general technology

Extraction

Confidence
95%
Detected
Sep 4, 2026
signal_type
news
signal_subtype
launches

Use this data

Get every launch signal for Agilent and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Agilent this week?”

  2. Send it to your own tools

    The Signal API returns launch signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/3a21cf7a-8019-d8c1-1ae9-433141874dc8 returns this record as JSON. POST /v1/companies/enrich returns every signal for agilent.com.

{
  "signal_id": "3a21cf7a-8019-d8c1-1ae9-433141874dc8",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-09-04T17:50:06+00:00",
  "company": {
    "name": "Agilent",
    "domain": "agilent.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/agilent-technologies-stock-gains-on-digital-pathology-launch-and-strong-q3/70056048",
    "title": "Agilent Technologies stock gains on digital pathology launch and strong Q3 figures - AD HOC NEWS",
    "excerpt": "Agilent Technologies Inc (ISIN US00846U1016) stock is quoted at 149.98 USD as of September 4, 2026, only 1.1% above an intrinsic value estimate of 148.35 USD, according to data compiled by GuruFocus . On the same day, Agilent announced the U.S. launch of its Agilent S540MD Slide Scanner System following FDA approval, adding a new digital pathology solution to its diagnostics portfolio as highlighted in the news feed at StockTitan . For investors, the combination of a nearly fair valuation and fresh product momentum sets the tone for Agilent Technologies stock today. On September 4, 2026, Agilent Technologies expanded its digital pathology offering in the U.S. with the launch of the Agilent S540MD Slide Scanner System after receiving FDA clearance, according to the company press summary carried in the StockTitan news stream. The scanner is designed for high volume pathology laboratories and can process up to 540 slides, with continuous loading and compatibility with standard racks as described by GuruFocus. That capacity matters because large hospital and reference labs increasingly seek automated workflows that digitize glass slides and integrate into clinical information systems. The S540MD platform uses automated scanning and advanced tissue detection technologies to accelerate slide digitization and support comprehensive digital pathology workflows, again per the technical...",
    "product": "Agilent S540MD Slide Scanner System",
    "summary": "Agilent Technologies launched its Agilent S540MD Slide Scanner System in the U.S. after receiving FDA clearance.",
    "location": "United States",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2698460_1920_1080.webp",
    "confidence": 0.95,
    "product_data": {
      "name": "Agilent S540MD Slide Scanner System",
      "full_text": "Agilent S540MD Slide Scanner System",
      "fuzzy_match": false,
      "release_type": "system"
    },
    "product_tags": [
      "medical",
      "general_technology"
    ],
    "published_at": "2026-09-04T17:50:06Z",
    "location_data": [
      {
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-09-04",
    "article_sentence": "On September 4, 2026, Agilent Technologies expanded its digital pathology offering in the U.S. with the launch of the Agilent S540MD Slide Scanner System after receiving FDA clearance, according to the company press summary carried in the StockTitan news stream."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.